Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29980331

Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Eur Urol
Publication date
2018 Oct
First author
Nabid A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Eur Urol. 2018 Oct;74(4):442-443. doi: 10.1016/j.eururo.2018.06.026.
    note
    Source null
    related pmid
    30041988
    relationship
    Comment in
  2. citation
    Eur Urol. 2019 Mar;75(3):e61-e62. doi: 10.1016/j.eururo.2018.10.030.
    note
    Source null
    related pmid
    30670365
    relationship
    Comment in
  3. citation
    Eur Urol. 2019 Mar;75(3):e63. doi: 10.1016/j.eururo.2018.10.029.
    note
    Source null
    related pmid
    30773206
    relationship
    Comment in
  4. citation
    Strahlenther Onkol. 2019 Aug;195(8):764-766. doi: 10.1007/s00066-019-01470-5.
    note
    Source null
    related pmid
    31073701
    relationship
    Comment in

Authors and identifiers

  1. name
    Nabid A
    type
    Author
  2. name
    Carrier N
    type
    Author
  3. name
    Martin AG
    type
    Author
  4. name
    Bahary JP
    type
    Author
  5. name
    Lemaire C
    type
    Author
  6. name
    Vass S
    type
    Author
  7. name
    Bahoric B
    type
    Author
  8. name
    Archambault R
    type
    Author
  9. name
    Vincent F
    type
    Author
  10. name
    Bettahar R
    type
    Author
  11. name
    Duclos M
    type
    Author
  12. name
    Garant MP
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Nabid A
    type
    Author
  2. name
    Carrier N
    type
    Author
  3. name
    Martin AG
    type
    Author
  4. name
    Bahary JP
    type
    Author
  5. name
    Lemaire C
    type
    Author
  6. name
    Vass S
    type
    Author
  7. name
    Bahoric B
    type
    Author
  8. name
    Archambault R
    type
    Author
  9. name
    Vincent F
    type
    Author
  10. name
    Bettahar R
    type
    Author
  11. name
    Duclos M
    type
    Author
  12. name
    Garant MP
    type
    Author
bibliography ids
  1. nci-bib-773c8e79bda3b03a8f98b479
book metadata
content sha256
db4fa3c4fce9d0b53e7e5f171a92d8f6dce0215bf4ad7da43aad86f7485770e3
document type
citation
dois
  1. 10.1016/j.eururo.2018.06.018
electronic publication date
display
2018 Jul 3
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:29980331
immutable id
pubmed:29980331@db4fa3c4fce9d0b53e7e5f171a92d8f6dce0215bf4ad7da43aad86f7485770e3
journal
abbreviation
Eur Urol
issn electronic
1873-7560
issn print
0302-2838
issue
4
name
European urology
nlm unique id
7512719
pages
432-441
volume
74
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Eur Urol. 2018 Oct;74(4):442-443. doi: 10.1016/j.eururo.2018.06.026.
    note
    Source null
    related pmid
    30041988
    relationship
    Comment in
  2. citation
    Eur Urol. 2019 Mar;75(3):e61-e62. doi: 10.1016/j.eururo.2018.10.030.
    note
    Source null
    related pmid
    30670365
    relationship
    Comment in
  3. citation
    Eur Urol. 2019 Mar;75(3):e63. doi: 10.1016/j.eururo.2018.10.029.
    note
    Source null
    related pmid
    30773206
    relationship
    Comment in
  4. citation
    Strahlenther Onkol. 2019 Aug;195(8):764-766. doi: 10.1007/s00066-019-01470-5.
    note
    Source null
    related pmid
    31073701
    relationship
    Comment in
outcomes validated
false
pmid
29980331
provenance
batch id
c4c0356d060413f719c2
provider
NCBI PubMed ESummary
record sha256
66f9b03029b946a13d91354b7a1c0c0e5167ea3c3f65432074c1fe749b3b10dc
response sha256
adeb6beaad718f060a94981fd9e96a2eaddc4f781839549cb3e53cba822117c0
retrieved at
2026-09-09T23:47:33.674758+00:00
publication date
display
2018 Oct
precision
month
year
2018
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
  6. Equivalence Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29980331/
title
Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial.

Preserved source evidence · Not medical advice